home / stock / qlgn / qlgn news


QLGN News and Press, Qualigen Therapeutics Inc. From 08/25/20

Stock Information

Company Name: Qualigen Therapeutics Inc.
Stock Symbol: QLGN
Market: NASDAQ
Website: qualigeninc.com

Menu

QLGN QLGN Quote QLGN Short QLGN News QLGN Articles QLGN Message Board
Get QLGN Alerts

News, Short Squeeze, Breakout and More Instantly...

QLGN - Qualigen picks up a bull who sees a two-bagger after release of COVID-19 test

Alliance Global Partners upgrades Qualigen ( QLGN +4.0% ) to Buy with a $10 (107% upside) price target. In a note, analyst James Molloy regards the company as a "compelling opportunity" in cancer detection and treatment. More news on: Qualigen Therapeutics, Inc., Healthcare stocks news, ...

QLGN - Qualigen nabs new U.S. patent for STARS technology

The USPTO has issued a new patent to Qualigen Therapeutics (NASDAQ: QLGN ) entitled "Devices and Methods for On-Line Whole Blood Treatment" regarding Company's Selective Target Antigen Removal System (STARS) technology. More news on: Qualigen Therapeutics, Inc., Healthcare stocks news,...

QLGN - Qualigen Therapeutics Announces Issuance of STARS(TM) Technology Patent by the U.S. Patent and Trademark Office

CARLSBAD, Calif. , Aug. 20, 2020 /PRNewswire/ --  Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the United States Patent and Trademark Office has issued patent No. 10,744,257 entitled "Devices and Methods for On-Line Whole Blood Treatment"...

QLGN - More on Qualigen Therapeutics FQ1 earnings

For  FQ1 , Qualigen Therapeutics ( QLGN -5.3% ) reported revenue of $0.9M (-40.4% Y/Y), led by a decrease in patient visits to physician offices, clinics and small hospitals amid pandemic, which reduced the number of FastPack tests performed. More news on: Qualigen Therapeutics, I...

QLGN - Qualigen Therapeutics, Inc. (QLGN) CEO Michael Poirier on Q1 2021 Results - Earnings Call Transcript

Qualigen Therapeutics, Inc. (QLGN) Q1 2021 Results Conference Call August 18, 2020 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Michael Poirier - Chairman, President and CEO Christopher Lotz - Chief Financial Officer Conference Call Participants ...

QLGN - Stocks To Watch: Walmart, Target, Kandi And Gold vs. Bitcoin

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

QLGN - Qualigen Therapeutics reports FQ1 results

Qualigen Therapeutics (NASDAQ: QLGN ) : FQ1 GAAP EPS of -$2.12. More news on: Qualigen Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

QLGN - Qualigen Therapeutics Announces Business Highlights and First Quarter Fiscal Year 2021 Financial Results; Has $16 Million in Cash on Hand as of Today

CARLSBAD, Calif. , Aug. 14, 2020 /PRNewswire/ --  Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) today announced business highlights and financial results for the fiscal year 2021 first quarter, ended June 30, 2020 . Business highlights for the fiscal first...

QLGN - Seeking Alpha Catalyst Watch

Volatility watch: Some of the volatility names to watch include Colony Capital (NYSE: CLNY ) , American Eagle Outfitters (NYSE: AEO ) and Brookfield Property Partners (NASDAQ: BPY ) with short interest positions on the rise. Virgin Galactic (NYSE: SPCE ) and National Beverage (NAS...

QLGN - Qualigen Therapeutics to Host Business Update Conference Call on August 18, 2020

CARLSBAD, Calif. , Aug. 6, 2020 /PRNewswire/ --  Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that it will host a business update conference call and live webcast on Tuesday, August 18, 2020 at 4:30 p.m. Eastern time . During the call,...

Previous 10 Next 10